Biolife Solutions Inc
Research Biolife Solutions Inc (BLFS) on Bullrun: market cap USD 1.82B, P/E 38.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBLFS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 1.82B
- P/E38.5
- Financial periodQ2 2026
- RevenueUSD 28.47M
- Net incomeUSD 45.10M
- Free cash flowUSD 5.19M
- Gross margin64.2%
Valuation Snapshot
latest market cap is USD 1.82B; P/E is 38.5.
Peer valuation comparison
Latest P/E is 38.49x versus a Healthcare sector median of 24.46x (57.4% above).
Latest P/E is 38.49x versus a United States median of 24.87x (54.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 96.21M | -USD 4.60M | USD 10.64M | 64.6% | -0.1 | USD 33.04M | USD 5.00M | USD 371.89M |
| FY2024 | USD 74.65M | -USD 20.18M | USD 5.20M | 67.1% | -0.44 | USD 91.54M | USD 15.94M | USD 348.91M |
| FY2023 | USD 68.02M | -USD 68.00M | -USD 18.88M | 60.7% | -1.55 | USD 27.90M | USD 23.85M | USD 337.66M |
| FY2022 | USD 76.24M | -USD 139.81M | -USD 18.87M | n/a | -3.25 | USD 19.44M | USD 25.61M | USD 364.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.82B | 38.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.17B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.22B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 732.02M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 778.34M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.56B | n/a | n/a | n/a |
About Biolife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biolife Solutions Inc's market cap?
Biolife Solutions Inc's market capitalization is USD 1.82B.
What is Biolife Solutions Inc's P/E ratio?
Biolife Solutions Inc's price-to-earnings (P/E) ratio is 38.5.
What does Biolife Solutions Inc do?
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.